1. Home
  2. HRMY vs PICS Comparison

HRMY vs PICS Comparison

Compare HRMY & PICS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$32.44

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

PICS

PicS N.V. Class A Common Shares

N/A

Current Price

$11.61

Market Cap

1.5B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
HRMY
PICS
Founded
2017
2012
Country
United States
Brazil
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
HRMY
PICS
Price
$32.44
$11.61
Analyst Decision
Buy
Strong Buy
Analyst Count
9
6
Target Price
$44.11
$22.00
AVG Volume (30 Days)
799.5K
291.9K
Earning Date
05-07-2026
05-30-2026
Dividend Yield
N/A
N/A
EPS Growth
7.97
N/A
EPS
2.71
N/A
Revenue
$868,453,000.00
N/A
Revenue This Year
$19.75
$33.65
Revenue Next Year
$12.88
$39.85
P/E Ratio
$11.72
$29.44
Revenue Growth
21.51
N/A
52 Week Low
$25.52
$9.88
52 Week High
$40.87
$18.49

Technical Indicators

Market Signals
Indicator
HRMY
PICS
Relative Strength Index (RSI) 66.25 42.18
Support Level $32.13 $9.88
Resistance Level $33.21 $14.65
Average True Range (ATR) 1.32 0.83
MACD 0.19 -0.08
Stochastic Oscillator 58.88 10.48

Price Performance

Historical Comparison
HRMY
PICS

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About PICS PicS N.V. Class A Common Shares

PicS NV is a digital payments company. The company operates a peer-to-peer (P2P) transfer platform that enables individuals to send money via mobile devices. It provides digital wallets, instant payments (Pix), P2P transfers, credit cards, loans, investments, insurance, and SMB payment solutions. The company has four reportable segments: Consumer Banking, Small and Medium-Sized Businesses, Audiences and Ecosystem Integration, and Institutional. The majority of the company's revenue is derived from the Consumer Banking segment, which generates revenue from various transaction activities occurring in the digital wallet, such as Pix, peer-to-peer (P2P) transfers, and bill payments.

Share on Social Networks: